STIRLING ANGLIAN PHARMACEUTICALS LIMITED
Get an alert when STIRLING ANGLIAN PHARMACEUTICALS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-07-24 (in 2mo)
Last made up 2025-07-10
Watchouts
None on the register
Cash
£2M
+7.4% highest in 5 filed years
Net assets
£6M
+69.8% highest in 5 filed years
Employees
7
0% vs 2023
Profit before tax
£3M
+113% vs 2023
Net assets
5-year trend · vs Health Care median
Accounts
5-year trend · latest reflected 2024-12-31
| Metric | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Turnover | — | — | — | £14,140,458 | £16,244,167 | |
| Operating profit | — | — | — | £1,216,897 | £2,594,218 | |
| Profit before tax | — | — | — | £1,218,264 | £2,595,201 | |
| Net profit | — | — | — | £1,218,264 | £2,595,201 | |
| Cash | £132,051 | £675,633 | £651,800 | £1,897,921 | £2,038,775 | |
| Total assets less current liabilities | £272,450 | £152,669 | £1,869,144 | £3,718,020 | £6,313,221 | |
| Net assets | -£1,117,674 | -£730,228 | £879,976 | £3,718,020 | £6,313,221 | |
| Equity | -£1,117,674 | -£730,228 | £879,976 | £3,718,020 | £6,313,221 | |
| Average employees | 4 | 4 | 4 | 7 | 7 | |
| Wages | — | — | — | £514,905 | £582,168 | |
| Directors' remuneration | — | — | — | £943,125 | £1,006,895 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+14.9%
£14,140,458 £16,244,167
-
Cash
+7.4%
£1,897,921 £2,038,775
highest in 5 filed years
-
Net assets
+69.8%
£3,718,020 £6,313,221
highest in 5 filed years
-
Employees
0%
7 7
-
Operating profit
+113.2%
£1,216,897 £2,594,218
-
Profit before tax
+113%
£1,218,264 £2,595,201
-
Wages
+13.1%
£514,905 £582,168
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Operating margin | — | — | — | 8.6% | 16.0% | |
| Net margin | — | — | — | 8.6% | 16.0% | |
| Return on capital employed | — | — | — | 32.7% | 41.1% | |
| Current ratio | — | — | — | 2.13x | 2.72x | |
| Interest cover | — | — | — | — | 47.19x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- STIRLING ANGLIAN PHARMACEUTICALS LIMITED 2013-07-12 → present
- STIRLING ANGLIAN LIMITED 2013-06-26 → 2013-07-12
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors are of the opinion that the company can meet its obligations as they fall due for the foreseeable future. The company has a healthy net assets position and a positive bank balance. The directors have prepared budgets and cash flow projections that show the company will be profitable for the foreseeable future. On this basis, the directors consider it appropriate to prepare the financial statements on the going concern basis.”
Group structure
- STIRLING ANGLIAN PHARMACEUTICALS LIMITED · parent
- Kelso Pharma Ireland Limited 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| INKER, Mark Charles | Director | 2023-02-20 | Jun 1964 | British |
| KING, Alan Fernie | Director | 2025-07-29 | Aug 1973 | British |
| MCLEAN, Andrew Firth | Director | 2021-12-21 | Aug 1965 | British |
| STRATFORD, Harry Thomas, Dr | Director | 2021-12-21 | Nov 1970 | British |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALSOP, Matthew Robert | Director | 2013-10-09 | 2016-10-13 |
| COOK, Mark | Director | 2013-10-09 | 2021-12-21 |
| FARQUHARSON, Carol Ann | Director | 2014-01-31 | 2017-01-04 |
| MCMENEMY, Philip, Dr | Director | 2013-10-09 | 2016-09-05 |
| NEUMAIER, Gerhard Wilhelm | Director | 2014-07-15 | 2017-07-14 |
| PERRIE, Sean Ambrose | Director | 2013-06-26 | 2021-12-21 |
| SCULLION, Stephen Peter | Director | 2015-02-01 | 2016-10-14 |
| THORBURN, Alastair | Director | 2013-10-09 | 2014-12-31 |
| WATSON, Allan Mark | Director | 2021-12-21 | 2025-07-28 |
| WESTAWAY, Karen Mary | Director | 2013-10-09 | 2015-04-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Kelso International Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-12-21 | Active |
| Mr Sean Ambrose Perrie | Individual | Shares 50–75% | 2016-04-06 | Ceased 2021-12-21 |
Filing timeline
Last 20 of 85 total filings
Material constitutional events — rename, articles re-file, resolution
- 2022-01-19 MA Memorandum articles
- 2022-01-19 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-08-12 | AA | accounts | Accounts with accounts type full | |
| 2025-07-30 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-30 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-24 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-02-18 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-01-31 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-10-07 | AA | accounts | Accounts with accounts type full | |
| 2024-07-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-02 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-08-08 | AA | accounts | Accounts with accounts type small | |
| 2023-07-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-05-02 | AD02 | address | Change sail address company with old address new address | |
| 2023-02-21 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-29 | AA | accounts | Accounts with accounts type unaudited abridged | |
| 2022-08-05 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-01-19 | AD03 | address | Move registers to sail company with new address | |
| 2022-01-19 | AD02 | address | Change sail address company with new address | |
| 2022-01-19 | MA | incorporation | Memorandum articles | |
| 2022-01-19 | RESOLUTIONS | resolution | Resolution |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.